Every recall we track for Rising Pharma Holding, Inc. — 13 in all — plus the complaints and injury reports the public filed about them.
Rising Pharma recalls cyproheptadine syrup with crystallized particles that may cause medication issues. Affected lots manufactured between 2025-2028 in the US. Stop using and contact for remedy.
Rising Pharma recalls 5mg Temozolomide capsules with impurities detected in stability testing. Patients should contact their doctor for alternative treatment options.
Rising Pharma recalls 25mg/100mg/200mg Carbidopa Levodopa Entacapone tablets (NDC 16571-691-01) because some bottles contain higher strength tablets (37.5mg/150mg/200mg) instead of the labeled strength.
Rising Pharma recalls 1,000-count Duloxetine 30mg capsules (NDC 57237-018-99) due to potential N-nitroso-duloxetine impurity above safety limits. Rx only product distributed by Rising Health, LLC.
Rising Pharma recalls 20mg Duloxetine capsules due to potential N-nitroso impurity above safety limits. Rx-only bottles with specific lot numbers and expiration dates are affected.
Rising Pharma recalls Duloxetine DR Capsules 60mg bottles due to N-nitroso-duloxetine impurity exceeding safety limits. Consumers should check lot numbers and contact the company for details.
Rising Pharma recalls 30-count and 1000-count Duloxetine 30mg capsules due to potential N-nitroso-duloxetine impurity above safety limits. This may pose health risks.
Rising Pharma recalls 20mg Duloxetine Delayed-Release Capsules (NDC 57237-017-60) with specific lot numbers due to presence of N-nitroso-duloxetine impurity above safety limits. Consumers should check their bottles for listed lot numbers and contact the company for guidance.
Rising Pharma recalls Duloxetine Delayed-Release Capsules 30mg (NDC 57237-018-30) and 90mg (NDC 57237-018-90) due to presence of N-nitroso-duloxetine impurity above safety limits. This may pose health risks.
Rising Pharma recalls Duloxetine DR Capsules 60mg (NDC 57237-019-30, 57237-019-90, 57237-019-99) due to presence of N-nitroso-duloxetine impurity above safety limits. Consumers should check product details and contact Rising Pharma for guidance.
Rising Pharma recalls 0.05% Diflorasone Diacetate Ointment (60g tube) made by Lyne Labs. Impurities detected at 12 months stability testing may pose safety risks. Consumers should contact the manufacturer for details.
Rising Pharma is recalling 1000-count Pregabalin 50mg capsules due to foreign tablets found during packaging. This is a safety issue for prescription users.
Rising Pharma recalls 150mg buPROPion XL tablets due to foreign tablets present. This is a prescription-only product with specific lot numbers and expiration dates.
